Herpes Zoster in Autologous Hematopoietic Cell Transplant Recipients in the Era of Acyclovir or Valacyclovir Prophylaxis and Novel Treatment and Maintenance Therapies
Herpes zoster occurred in 21% of autologous transplant recipients over 5 years Acyclovir or valacyclovir prophylaxis were protective for herpes zoster when in use Durable strategies are needed to prevent herpes zoster after autologous transplantation